Media

• Industry-Academia Collaboration Formed to Improve Cell and Gene Therapy Manufacturing
  GEN Eng News - 25.11.2025
• Swiss Biotech: Depth, Breadth & Scaling Up
  Pharma Boardroom - 18.11.2025
• Limula’s LimONE System Targets Consistency in Stem Cell Transplants
  BioPharm International - 15.09.2025
• Three life sciences startups recognized for growth potential
  Startupticker - 04.08.2025
• Regeneration Nation: 5 Swiss Biotechs Rewriting the Rules of Medicine
  Pharma Boardroom - 25.06.2025
• BIO2025: Fit-for-Purpose Manufacturing for Personalized Therapy
  The Pharma Navigator - 11.06.2025
• Limula: Unlocking the full potential of cell therapies with automation
  Verve - 07.06.2025
• Limula’s End-to-End Cell Processing Platform Enters Beta Testing
  GEN Eng News - 06.06.2025
• Personalized therapies are transforming medicine
  globalance - 29.04.2025
• Breakthrough Solution in end-to-end cell therapy manufacturing unveiled
  Startupticker - 07.03.2025
• Limula unveils automated cell therapy tech
  BioProcess International - 03.03.2025
• IMD-connected startups raised CHF 350m in 2024
  IMD - 14.02.2025
• Limula répond aux besoins des thérapies cellulaires
  24heures - 27.05.2024
• Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies
  EU Startups - 21.05.2024
• Biotech Limula secures $6.8M for gene therapy
  tech.eu - 21.05.2024
• Swiss startup creates modular device for on-demand cell therapy manufacturing
  The Next Web - 21.05.2024

Previous123Next